Skip to main content

Dominic Pilon, MA

Authored Items
Medication Adherence, Treatment Patterns, and Dose Reduction in Patients with Metastatic Castration-Resistant Prostate Cancer Receiving Abiraterone Acetate or Enzalutamide
Gary M. Owens, MD, Ajay S. Behl, PhD, Lorie A. Ellis, PhD, Dominic Pilon, MA, Yongling Xiao, PhD
September 2017 Vol 10, No 6 in Original Research
Assessment of Real-World Central Nervous System Events in Patients with Advanced Prostate Cancer Using Abiraterone Acetate, Bicalutamide, Enzalutamide, or Chemotherapy
Dominic Pilon, MA, Brian Caveney, MD, JD, MPH, Ajay S. Behl, PhD, Lorie A. Ellis, PhD, Marie-Noëlle Robitaille, MA, Patrick Lefebvre, MA, Nancy A. Dawson, MD
May 2017 Vol 10, No 3 in Original Research
Treatment Sequences and Pharmacy Costs of 2 New Therapies for Metastatic Castration-Resistant Prostate Cancer
Lorie A. Ellis, PhD, Laurence Gozalo, PhD, Marie-Hélène Lafeuille, MA, Patrick Lefebvre, MA, Scott McKenzie, MD, Dominic Pilon, MA, Matthew Mitchell, PharmD, MBA, FAMCP
June 2015, Vol 8, No 4 in Practice Management
Last modified: April 23, 2019